Viollier AG Report issue

For profit Phase 2
Founded: Basel Switzerland (1953)
Status: No NME R&D (1953)

Organization Overview

First Clinical Trial
2005
NCT00942591
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Alternative names

Laboratory: Viollier AG Spalenring 145 / 147 Postfach 4002 Basel | Viollier AG, Basel, Switzerland

Active Ingredients

Drugs in Phase 2 Trials (2)

atorvastatin (lipitor) (2 trials)

interferon beta-1b (betaseron) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Multiple Sclerosis (Phase 2)

Multiple Sclerosis, Relapsing-Remitting (Phase 2)

Sclerosis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2